Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with

Anita Thapar1, Kate Langley, Tom Fowler

  • 1Department of Psychological Medicine, College of Medicine, School of Psychology, Cardiff University, Heath Park, Cardiff, Wales. thapar@cardiff.ac.uk

Insights

A specific catechol O-methyltransferase (COMT) gene variant and lower birth weight predict early-onset antisocial behavior. The val/val genotype increases susceptibility to prenatal risks, highlighting gene-environment interactions.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Psychology

Background:

  • Early-onset antisocial behavior (ASB) with attention-deficit/hyperactivity disorder (ADHD) is a severe variant with poor outcomes.
  • Identifying early predictors is crucial for intervention.
  • Prefrontal cortical function, influenced by the COMT gene variant, is implicated.

Purpose of the Study:

  • To test if the COMT gene variant predicts early-onset ASB in a high-risk sample.
  • To examine the effects of birth weight (a prenatal adversity index) on ASB.
  • To investigate genotype x birth weight interactions.

Main Methods:

  • A family-based genetic study conducted from 1997-2003 in the UK.
  • Prospective recruitment of 240 clinic children diagnosed with ADHD or hyperkinetic disorder.
  • Standardized assessments of ASB, IQ, and DSM-IV conduct disorder symptoms.

Main Results:

  • Significant main effects for the COMT gene variant (P = .002).
  • Significant main effects for birth weight (P = .002).
  • A significant gene x environment interaction (COMT x birth weight) was observed (P = .006).

Conclusions:

  • The COMT gene variant and birth weight predict early-onset ASB in high-risk children.
  • Individuals with the val/val genotype are more vulnerable to prenatal risks (lower birth weight).
  • This highlights the interplay between genetic predisposition and environmental factors in ASB development.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
Genetic Lingo01:11

Genetic Lingo

Overview